Home Visit app to optimize virtual clinical trials

07 May 2020

Cmed Technology announced today the encapsia Home Visit app is now available to capture and manage clinical trial data from patients at home or in the community. The app works seamlessly with all the other encapsia apps, including web EDC (Entry app) and direct data capture (esource app) to provide tremendous flexibility in the choice of data capture methods both before and during a study. This helps maintain patient participation and clinical data flow which is particularly compelling to minimize disruption during the COVID-19 pandemic as well as in the new landscape for clinical trials that is expected to follow.

Support for Virtual Clinical Trials from Cmed

30 Apr 2020

The dramatic coronavirus (COVID-19) pandemic has disrupted all aspects of daily life including clinical trials. Medical staff limitations and reorganizations, travel bans and access restrictions to medical facilities have challenged sponsors and sites’ current clinical trial processes.
The coronavirus outbreak has effectively forced a change in patient care and clinical trials. To continue bringing new therapies to market and support patients, sites and sponsors have accelerated the adoption of new technologies into decentralized trials or hybrid trials.

A message for our clients, investigator sites and industry partners

06 Apr 2020

The global COVID-19 crisis has fundamentally impacted the way we live our lives as well as the operation of the entire drug development community. During the early stages of the pandemic the Cmed leadership team has implemented a number of measures to ensure the safety of our employees, clients and partners, as well as ensuring the continued delivery of our CRO services and our encapsia clinical data system. Our goal has been to minimise the impact of COVID-19 on our business, our clients, investigator sites and patients.

Cmed reaches 20-year anniversary

Written by Cmed

Cmed was founded in 2000 and has since helped our sponsors deliver several hundreds of complex clinical trials spanning all phases. While we continue to provide Data & Analytics solutions and an exceptional technology offering with encapsia, we have also flourished as a global full service, technology-led CRO.

Cmed’s strong expertise, systems and collaborative approach have been at the heart of the company’s growth. Our team has a wealth of experience from exposure to a wide range of study designs. With 100% of our team experienced in oncology, our talented people deliver oncology, immuno-oncology and rare diseases clinical trials.

Our practical experience of clinical trials has been harnessed into the development of encapsia, the game-changing clinical data suite. It allows the capture, management and real-time review of all clinical trial data within one platform, including EDC, eSource and third-party data.

To mark our 20-year anniversary, we are renewing our commitment to deliver results to the highest quality and help bring life-saving medicines to market.